Claudia I. Henschke

Icahn School of Medicine at Mount Sinai

Papers

2

Total Citations

12

H-Index

2

About

Claudia I. Henschke is a pioneering thoracic surgeon and researcher whose work has fundamentally shaped the management of early-stage lung cancer. Her research centers on optimizing treatment strategies and patient-centered outcomes for non-small cell lung cancer (NSCLC), with a particular focus on minimally invasive surgical techniques and radiation therapy. Henschke has made major contributions by leading prospective studies that compare quality of life (QoL) outcomes across different treatment modalities. Her 2024 study on sublobar resection versus stereotactic body radiation therapy (SBRT) provides critical longitudinal QoL data for patients ineligible for lobectomy, while her 2025 work comparing robotic-assisted thoracic surgery (RATS) to video-assisted thoracoscopic surgery (VATS) offers novel insights into postoperative physical and mental health recovery. These studies, though recent, have already garnered significant attention (9 and 3 citations respectively), reflecting their immediate impact on clinical decision-making. Henschke’s dedication to patient-centered research—prioritizing how treatments affect daily life rather than just survival—positions her as a leading voice in the evolving landscape of lung cancer care, where quality of life is increasingly recognized as a vital outcome measure.

Research Focus

Key Achievements

2
H-Index
2
Papers
12
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Longitudinal quality of life after sublobar resection and stereotactic body radiation therapy for early‐stage non–small cell lung cancer
9 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: Icahn School of Medicine at Mount Sinai

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago